Form4insider filings, from the source

SEC Form 4 · accession 0001645627-18-000028

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 18, 2018
Accepted (ET)
May 23, 2018 · 4:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMay 18, 2018P1,000$0.0518A25,075,889D
Common StockMay 18, 2018P1,000$0.053A25,076,889D
Common StockMay 18, 2018P1,000$0.0536A25,077,889D
Common StockMay 18, 2018P1,000$0.0536A25,078,889D
Common StockMay 18, 2018P1,000$0.0536A25,079,889D
Common StockMay 18, 2018P1,000$0.0536A25,080,889D
Common StockMay 18, 2018P1,000$0.0526A25,081,889D
Common StockMay 18, 2018P1,000$0.0526A25,082,889D
Common StockMay 18, 2018P1,000$0.0526A25,083,889D
Common StockMay 18, 2018P1,000$0.0526A25,084,889D
Common StockMay 18, 2018P1,000$0.0526A25,085,889D
Common StockMay 18, 2018P1,000$0.0526A25,086,889D
Common StockMay 18, 2018P1,000$0.0526A25,087,889D
Common StockMay 18, 2018P1,000$0.0528A25,088,889D
Common StockMay 18, 2018P1,000$0.0528A25,089,889D
Common StockMay 18, 2018P1,000$0.0552A25,090,889D
Common StockMay 21, 2018P1,000$0.057A25,091,889D
Common StockMay 21, 2018P1,000$0.06A25,092,889D
Common StockMay 21, 2018P1,000$0.0564A25,093,889D
Common StockMay 21, 2018P1,000$0.059A25,094,889D
Common StockMay 21, 2018P1,000$0.0585A25,095,889D
Common StockMay 21, 2018P1,000$0.0577A25,096,889D
Common StockMay 21, 2018P1,000$0.059A25,097,889D
Common StockMay 21, 2018P1,000$0.056A25,098,889D
Common StockMay 21, 2018P1,000$0.059A25,099,889D
Common StockMay 21, 2018P1,000$0.0593A25,100,889D

Table II — derivative securities

No Table II lines on this filing.